Loading clinical trials...
Loading clinical trials...
GW876008 is a drug which may change mans reaction to stress, by decreasing the fear, physical and behavior symptoms that people with SocAD experience in social situations.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
GlaxoSmithKline
NCT06564402 · Social Anxiety, Social Phobia
NCT05157386 · Depression, Physical Inactivity, and more
NCT02872051 · Generalized Anxiety, Social Phobia, and more
NCT03113175 · Panic Disorder, Generalized Anxiety Disorder, and more
NCT05987969 · Social Anxiety Disorder (Social Phobia), Social Anxiety, and more
GSK Investigational Site
Beverly Hills, California
GSK Investigational Site
Burbank, California
GSK Investigational Site
Temecula, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions